CN1147586C - Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列 - Google Patents

Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列

Info

Publication number
CN1147586C
CN1147586C CNB951963678A CN95196367A CN1147586C CN 1147586 C CN1147586 C CN 1147586C CN B951963678 A CNB951963678 A CN B951963678A CN 95196367 A CN95196367 A CN 95196367A CN 1147586 C CN1147586 C CN 1147586C
Authority
CN
China
Prior art keywords
hiv
vau
sequence
group
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB951963678A
Other languages
English (en)
Chinese (zh)
Other versions
CN1164258A (zh
Inventor
P
P·查尼恩
ά
F·克拉维尔
A·伯尔曼
C·奎兰特
D·古塔尔德
L·蒙塔格尼尔
J·当约恩迪萨恩特马丁
M
J·H·M·库翰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26231483&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1147586(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9412554A external-priority patent/FR2726006B1/fr
Priority claimed from FR9502526A external-priority patent/FR2731225B1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of CN1164258A publication Critical patent/CN1164258A/zh
Application granted granted Critical
Publication of CN1147586C publication Critical patent/CN1147586C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CNB951963678A 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列 Expired - Lifetime CN1147586C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9412554A FR2726006B1 (fr) 1994-10-20 1994-10-20 Sequences nucleotidiques codant des antigenes d'un retrovirus du type vih-1 groupe o
FR94/12554 1994-10-20
FR9502526A FR2731225B1 (fr) 1995-03-03 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
FR95/02526 1995-03-03

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN2010102008955A Division CN102134609A (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN2004100078820A Division CN1651457B (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列

Publications (2)

Publication Number Publication Date
CN1164258A CN1164258A (zh) 1997-11-05
CN1147586C true CN1147586C (zh) 2004-04-28

Family

ID=26231483

Family Applications (3)

Application Number Title Priority Date Filing Date
CNB951963678A Expired - Lifetime CN1147586C (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN2010102008955A Pending CN102134609A (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN2004100078820A Expired - Lifetime CN1651457B (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN2010102008955A Pending CN102134609A (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN2004100078820A Expired - Lifetime CN1651457B (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列

Country Status (12)

Country Link
US (3) US6399294B1 (https=)
EP (2) EP0787191B2 (https=)
JP (4) JP4278174B2 (https=)
CN (3) CN1147586C (https=)
AT (1) ATE374253T1 (https=)
AU (3) AU715731B2 (https=)
CA (2) CA2202408C (https=)
DE (1) DE69535601T3 (https=)
DK (1) DK0787191T4 (https=)
ES (1) ES2293643T5 (https=)
PT (1) PT787191E (https=)
WO (1) WO1996012809A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374253T1 (de) * 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE69604051T2 (de) * 1995-01-27 1999-12-16 The Government Of The United States Of America, As Represented By The Secretary Verfahren zum sensitiven nachweis von reverser transcriptase
DE19505262C2 (de) * 1995-02-16 1998-06-18 Behring Diagnostics Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
FR2761993B1 (fr) * 1997-04-09 1999-05-21 Pasteur Sanofi Diagnostics Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
CZ300927B6 (cs) * 1997-04-09 2009-09-16 Bio-Rad Pasteur Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
FR2775287B1 (fr) * 1998-02-24 2000-11-24 Pasteur Sanofi Diagnostics Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
EP1003878A2 (en) * 1997-07-18 2000-05-31 Innogenetics N.V. Hiv-1 group o antigens and uses thereof
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
AU2345399A (en) * 1998-01-28 1999-08-16 Universal Health-Watch, Inc. Divergent hiv-1 peptides
CN1061092C (zh) * 1998-02-27 2001-01-24 中国科学院上海生物化学研究所 白色念珠菌具有逆转录转座子结构的元件
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
WO1999056128A1 (en) * 1998-04-30 1999-11-04 Universal Healthwatch, Inc. Immunoassay with mixed peptides
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
CA2290217C (en) * 1998-11-30 2010-01-12 Ortho-Clinical Diagnostics, Inc. Peptides for the detection of hiv-1 group o
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
EP2251442B9 (en) 2003-12-19 2012-04-25 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
TW200613554A (en) 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
EP2309269B1 (en) * 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Compositions and methods for the detection of HIV-1/HIV-2 infection.
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
CA2817418A1 (en) * 2010-11-10 2012-05-18 Laboratorios Del Dr. Esteve, S.A. Highly immunogenic hiv p24 sequences
EP2864787B1 (en) * 2012-06-22 2017-11-01 Bio-Rad Laboratories, Inc. Human factor xiii as a normalization control for immunoassays
US9823249B2 (en) * 2012-12-12 2017-11-21 Brigham And Women's Hospital, Inc. System and method for detecting pathogens
KR102056520B1 (ko) 2017-03-24 2019-12-18 (주)셀아이콘랩 인간 섬유아세포에서 콜라겐 합성 촉진 및 콜라겐 분해 효소 활성화 억제를 유도하는 펩타이드를 함유한 화장품 조성물 및 제조방법
CN108997482B (zh) 2018-08-09 2025-09-09 东莞市朋志生物科技有限公司 用于检测hiv-1的合成肽

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030714A (en) 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
CA1339363C (en) 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
DE3853422T2 (de) 1988-06-09 1995-10-26 Innogenetics Nv HIV-3-Retrovirus und seine Verwendung.
WO1990007119A1 (en) * 1988-12-20 1990-06-28 Immunodiagnostics, Inc. Synthetic hiv-like peptides, their compositions and uses
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
DE3934366A1 (de) * 1989-10-14 1991-04-18 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
IL99077A0 (en) 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
EP0854193A1 (en) * 1990-09-21 1998-07-22 Chiron Corporation Human retroviral packaging cell line
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
JP2541030B2 (ja) * 1991-04-22 1996-10-09 富士ゼロックス株式会社 ヒドロキシインジウムフタロシアニンの新規結晶及びそれを用いた電子写真感光体
SG77551A1 (en) * 1992-03-06 2005-04-28 Innogenetics Nv Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing
DE69311764T2 (de) 1992-05-14 1998-02-05 Polymun Scient Immunbio Forsch Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren
JP3207535B2 (ja) 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
ATE174382T1 (de) 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
AU7101294A (en) 1993-06-07 1995-01-03 Endocon, Inc. Implant stimulated cellular immunity
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
ATE374253T1 (de) * 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE19622088A1 (de) 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben

Also Published As

Publication number Publication date
CN1164258A (zh) 1997-11-05
AU2009213045B2 (en) 2012-12-20
US6399294B1 (en) 2002-06-04
JP2009240315A (ja) 2009-10-22
ATE374253T1 (de) 2007-10-15
US7157225B2 (en) 2007-01-02
CN1651457B (zh) 2010-07-28
DK0787191T4 (da) 2012-01-30
JPH10509587A (ja) 1998-09-22
US20080261197A1 (en) 2008-10-23
AU2005202281A1 (en) 2005-06-16
EP0787191A2 (fr) 1997-08-06
WO1996012809A3 (fr) 1996-06-20
AU2009213045A1 (en) 2009-10-08
EP0787191B2 (fr) 2011-10-26
DK0787191T3 (da) 2008-02-04
AU715731B2 (en) 2000-02-10
CN1651457A (zh) 2005-08-10
JP4589420B2 (ja) 2010-12-01
CN102134609A (zh) 2011-07-27
AU2005202281B2 (en) 2009-06-11
ES2293643T3 (es) 2008-03-16
PT787191E (pt) 2007-12-06
DE69535601T2 (de) 2008-07-10
EP1849869A2 (fr) 2007-10-31
JP2008271974A (ja) 2008-11-13
US20030049604A1 (en) 2003-03-13
DE69535601D1 (de) 2007-11-08
EP0787191B1 (fr) 2007-09-26
EP1849869A3 (fr) 2011-05-18
DE69535601T3 (de) 2012-04-05
CA2652992A1 (fr) 1996-05-02
AU3808995A (en) 1996-05-15
JP2010172335A (ja) 2010-08-12
CA2202408A1 (fr) 1996-05-02
JP4278174B2 (ja) 2009-06-10
CA2202408C (fr) 2012-03-06
ES2293643T5 (es) 2012-02-02
US8236324B2 (en) 2012-08-07
CA2652992C (fr) 2014-10-07
WO1996012809A2 (fr) 1996-05-02

Similar Documents

Publication Publication Date Title
CN1147586C (zh) Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
Simmonds et al. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis
Gheysen et al. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
EP0778888B1 (en) Antigenically-marked non-infectious retrovirus-like particles
US6451322B1 (en) Retrovirus like particles made non infectious by a plurality of mutations
US6291157B1 (en) Antigenically-marked non-infectious retrovirus-like particles
CN1852734A (zh) 共有/祖先免疫原
CN1333873A (zh) Hiv－特异的t－细胞诱导
CN87107837A (zh) 由重组体棒状病毒感染的昆虫细胞中的人类免疫缺陷病毒的壳膜基因得到的多肽
US6518030B1 (en) Antigentically-marked non-infectious retrovirus-like particles
CN1251614A (zh) 一种用于早期检测hiv感染的利用非变性hiv抗原的新型酶免疫试验
WO2003062377A2 (en) COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
AU780017B2 (en) Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
CN1606625A (zh) Hiv－1亚型分离株调节/附加基因及其修饰物和衍生物
Bäyon-Auboyer et al. Evolution of the human immunodeficiency virus type 2 envelope gene in preimmunized and persistently infected rhesus macaques
CN1615364A (zh) Hiv－1病毒tat－蛋白突变体
JPH06500230A (ja) レトロウイルスＳＩＶｃｐｚ―ａｎｔ及びその用途
HK1118308A (en) Nucleotide sequences of hiv-1 group (or sub-group) 0 retroviral antigens
Gnann Jr et al. Using synthetic peptide reagents to distinguish infections caused by different HIV strains
FR2731225A1 (fr) Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20040428

EXPY Termination of patent right or utility model